Purchases and Sales Made in Q2 2022 in Allogene Therapeutics, Inc. (ALLO)
This table provides information about the institutional ownership of Allogene Therapeutics, Inc. (ALLO) during Q2 2022. The information is specifically focused on institutions that hold shares of Allogene Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 12, 2022
Q2 2022
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-312K- 53.79% |
$2.11M - $3.83M
|
268K
$761K
|
|
|
Aug 12, 2022
Q2 2022
|
Rafferty Asset Management, LLC
New York, NY |
SELL
|
- |
-346K- 60.93% |
$2.35M - $4.25M
|
222K
$630K
|
|
|
Oct 27, 2022
Q2 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-551K- 32.64% |
$3.74M - $6.77M
|
1.14M
$3.23M
|
|
|
Aug 15, 2022
Q2 2022
|
Morgan Stanley
New York, NY |
SELL
|
- |
-551K- 32.64% |
$3.74M - $6.77M
|
1.14M
$3.23M
|
|
|
Aug 15, 2022
Q2 2022
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-701K- 71.2% |
$4.76M - $8.61M
|
284K
$806K
|
|
|
Aug 15, 2022
Q2 2022
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-795K- 83.33% |
$5.39M - $9.76M
|
159K
$452K
|
|
|
Aug 12, 2022
Q2 2022
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-975KClosed |
$6.61M - $12M
|
0
$0
|
|
|
Aug 15, 2022
Q2 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-987K- 33.33% |
$6.69M - $12.1M
|
1.97M
$5.61M
|
|
|
May 14, 2024
Q2 2022
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-1.36M- 40.82% |
$9.24M - $16.7M
|
1.97M
$5.61M
|
|
|
Aug 15, 2022
Q2 2022
|
State Street Corp
Boston, MA |
SELL
|
- |
-2.22M- 28.22% |
$15.1M - $27.3M
|
5.65M
$16.1M
|
|
|
Aug 15, 2022
Q2 2022
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-2.53M- 96.89% |
$17.2M - $31.1M
|
81.4K
$231K
|